無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の細胞治療市場における成長機会:〜2025年

Growth Opportunities in the Global Cell Therapy Market, Forecast to 2025

発行 Frost & Sullivan 商品コード 739355
出版日 ページ情報 英文 84 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.42円で換算しております。
Back to Top
世界の細胞治療市場における成長機会:〜2025年 Growth Opportunities in the Global Cell Therapy Market, Forecast to 2025
出版日: 2018年10月24日 ページ情報: 英文 84 Pages
概要

確実な製品パイプラインが世界の細胞治療市場に変革をもたらす画期的な併用療法の市場機会を創出しています。

当レポートでは、世界の細胞治療市場における成長機会を調査し、細胞治療市場のバリューチェーン、上市済み製品およびパイプライン製品の競合環境、市場成長への各種影響因子の分析、細胞治療市場の収益予測、新しいビジネスモデル、主要企業の成長戦略のケーススタディ、主な成長機会の分析などをまとめています。

第1章 エグゼクティブダッシュボード

第2章 成長環境:市場概要

  • 市場概要
  • 細胞治療のバリューチェーン
  • 慢性疾患治療へのパラダイムシフト
  • 幹細胞 vs 非幹細胞:地域的ハイライト
  • 競合環境:上市済み製品
  • 競合環境:パイプライン製品
  • バイプライン全体の内訳
  • 革新的な潜在的治療法
  • 推進因子と障壁
  • 産業課題

第3章 成長環境:市場予測

  • マーケットエンジニアリング測定
  • 予測前提因子
  • 収益予測
  • 収益予測に関するディスカッション

第4章 成長環境:競合戦略

  • 主要参入事業者:地域別
  • 主要市場のライフサイクル分析
  • 市場評価
  • 市場評価:米国
  • 市場評価:英国
  • 市場評価:ドイツ
  • 市場評価:日本
  • 市場評価:中国
  • 市場評価:韓国
  • 競合環境
  • 新しいビジネスモデル
  • ケーススタディ:Novartis・Avexis
  • ケーススタディ:MaSTherCell・Zelluna
  • ケーススタディ:Celgene・Bluebird Bio
  • 回避すべき点

第5章 ビジョニングシナリオ

  • マクロからミクロへのビジョニング
  • 市場に影響を及ぼす主な将来動向
  • 主なM&A・提携、など

第6章 成長機会・推奨行動

  • 産業エコシステムにおける変化
  • 成長のための戦略的必須要件

第5章 主な成長機会

  • 成長機会マトリックス
  • 成長機会:併用療法
  • 成長機会:焦点の多角化
  • 成長機会:提携による専門能力の獲得
  • 成長機会:CRISPR/Cas9によるゲノム編集
  • 成長機会:製造のオートメーションによるTIMの短縮

第7章 総論

  • 総論
  • 免責事項

第8章 付録

目次
Product Code: PA1F-52

A Robust Product Pipeline Creating Opportunities for Ground-breaking Combination Therapies to Revolutionize the Global Cell Therapy Market

The global pharmaceuticals industry is continuously evolving to meet the requirements of a changing disease landscape. With the increasing prevalence of chronic infectious diseases and cancer, market needs are shifting from traditional small molecules to novel large molecule therapies, with cell therapies dominating the space. This study presents an overview of the global cell therapy landscape, with emphasis on the key trends and growth opportunities shaping the market. It highlights the emerging business models supporting the development and manufacture of these novel therapies.

Due to the dynamic market landscape, Big pharma/bio-pharma players are looking to adopt a collaborative business approach by either signing co-development/ co-commercialization agreements or acquiring smaller niche players to gain a competitive advantage with respect to specific therapy areas or technology. The study also highlights some of the innovative payment models that will enhance patient access to these high-value therapies. In addition to the above-mentioned strategic analysis, the emerging business models of risk sharing and fast to market are also examined.

The study aims to identify some of the key growth opportunities for the next few years. It presents revenue analysis of the global cell therapy market at global and regional levels. It presents some of the key market drivers and restraints that affect growth. Additionally, it gives an insight into the leading future trends shaping the global market and their long-term implications. There is also focus on the regulatory challenges faced by disruptive players in terms of market expansion or supporting drug development across emerging markets including China and South Korea.

Key Issues Addressed:

  • How has the market for cell therapies evolved over the years? What is the future market potential?
  • What are the most promising segments? Which segment is attracting the most interest in terms of funding and innovation?
  • What are the current and future trends impacting the cell therapy market growth? What emerging business models are set to transform the market landscape?
  • What are some of the key regulatory challenges affecting the cell therapy market?
  • Who are the key participants making an impact on this market?
  • What are the market gaps that need to be addressed and are drawing new entrants?

Table of Contents

1. EXECUTIVE DASHBOARD

  • Purpose of this Experiential Study
  • 5-Step Process to Transformational Growth
  • Scope and Segmentation
  • Key Takeaways-How is this Market Important to You?
  • Market Segmentation-Next Wave of Cell Therapy
  • Key Findings
  • Market Engineering Measurements
  • 8 Big Market Themes
  • Key Questions this Study will Answer

2. GROWTH ENVIRONMENT-MARKET OVERVIEW

  • Methodology
  • Executive Summary-Market Snapshot
  • Cell Therapy Value Chain-Sample Collection to Therapy Infusion Cycle
  • Paradigm Shift to Chronic Disease Therapies
  • Stem Cell versus Non-Stem Cell-Regional Highlights
  • Competitive Landscape-Marketed Products
  • Competitive Landscape-Pipeline Products*
  • Competitive Landscape-Pipeline Products* (continued)
  • Overall Pipeline Breakdown
  • Potential Game Changing Therapies
  • Drivers and Restraints
  • Industry Challenges

3. GROWTH ENVIRONMENT-MARKET FORECASTS

  • Market Engineering Measurements
  • Revenue Forecast Assumptions
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Revenue Forecast Discussion (continued)
  • Revenue Forecast Discussion (continued)

4. GROWTH ENVIRONMENT-COMPETITIVE PLAYBOOK

  • Competitive Playbook-Key Market Participants by Region
  • Lifecycle Assessment of Leading Cell Therapy Markets
  • Market Assessment
  • Market Assessment-The United States
  • Market Assessment-The United Kingdom
  • Market Assessment-Germany
  • Market Assessment-Japan
  • Market Assessment-China
  • Market Assessment-South Korea
  • Competitive Landscape
  • Emerging Business Models in the Cell Therapy Market
  • Case Study 1-Novartis' Acquisition of Avexis
  • Case Study 2-MaSTherCell and Zelluna Manufacturing Collaboration
  • Case Study 3-Celgene's Co-development Partnership with Bluebird Bio
  • Pitfalls to Avoid

5. VISIONING SCENARIOS

  • Cell Therapy Market-Macro to Micro Visioning
  • Key Future Trends Impacting the Market
  • Alternative Payment Models-Why are they Required?
  • Payment Models across Cell Therapy Market
  • Key Mergers & Acquisitions and Partnerships
  • Technology-focused Collaborations
  • Therapeutic-focused Collaborations
  • Commercialization-focused Collaborations
  • Top Predictions for the Cell Therapy Market

6. GROWTH OPPORTUNITIES AND COMPANIES TO ACTION

  • Transformation in Industry Ecosystem
  • Strategic Imperatives for Growth
  • 5 Major Growth Opportunities
  • Growth Opportunity Matrix
  • Growth Opportunity 1-Curative Combination Therapies
  • Growth Opportunity 2-Diverse Therapeutic Focus
  • Growth Opportunity 3-Gaining Expertise through Collaborative Business Approach
  • Growth Opportunity 4-Genome Editing with CRISPR/Cas9
  • Growth Opportunity 5-Reducing Time to Market through Manufacturing Automation

7. CONCLUSION

  • The Last Word
  • Legal Disclaimer

8. APPENDIX

  • Abbreviations
  • Definitions-Cell Therapy and Stem Cell Therapy
  • Regenerative Medicine Industry-Key Stakeholders
  • Key Mergers & Acquisitions and Partnerships
  • Key Mergers & Acquisitions and Partnerships (continued)
  • Key Mergers & Acquisitions and Partnerships (continued)
  • List of Exhibits
  • List of Exhibits (continued)
Back to Top